Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD of Replimune Group, Inc. from 2016 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Replimune Group, Inc. quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and change rate from 2016 to Q2 2025.
  • Replimune Group, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 30 Jun 2025 was -$13.7M, a 118% decline year-over-year.
  • Replimune Group, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $36.7M.
  • Replimune Group, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was -$72.1M, a 277% decline from 2022.
  • Replimune Group, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $40.6M.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

Replimune Group, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$13.7M -$90.9M -118% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q2 2024 $77.2M +$117M 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q2 2023 -$40.1M -$46.4M -737% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q2 2022 $6.3M -$3.71M -37.1% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q2 2021 $10M -$35.3M -77.9% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q2 2020 $45.3M +$32.2M +246% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q2 2019 $13.1M +$16M 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q2 2018 -$2.9M 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019

Replimune Group, Inc. Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $36.7M +$109M 01 Apr 2024 31 Mar 2025 10-K 22 May 2025
2023 -$72.1M -$113M -277% 01 Apr 2023 31 Mar 2024 10-K 22 May 2025
2022 $40.6M +$117M 01 Apr 2022 31 Mar 2023 10-K 16 May 2024
2021 -$76.6M -$200M -162% 01 Apr 2021 31 Mar 2022 10-K 18 May 2023
2020 $123M +$88.8M +259% 01 Apr 2020 31 Mar 2021 10-K 19 May 2022
2019 $34.2M +$25M +271% 01 Apr 2019 31 Mar 2020 10-K 20 May 2021
2018 $9.23M +$12.2M 01 Apr 2018 31 Mar 2019 10-K 03 Jun 2020
2017 -$3.01M -$9.28M -148% 01 Apr 2017 31 Mar 2018 10-K 03 Jun 2020
2016 $6.27M 01 Apr 2016 31 Mar 2017 10-K 28 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.